NASDAQ: ERNA
Ernexa Therapeutics Inc Stock Ownership - Who owns Ernexa Therapeutics?

Insider buying vs selling

Have Ernexa Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Charles Cherington10% Owner2026-02-104,000,000$0.50
$2.00MBuy

1 of 1

ERNA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ERNA insiders and whales buy or sell their stock.

ERNA Shareholders

What type of owners hold Ernexa Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fidelity National Financial Inc2,354.23%38,430,766$113.76MInsider
Jeffrey Alan Berg1,279.85%20,892,428$61.84MInsider
Trinad Capital Master Fund Ltd545.21%8,900,093$26.34MInsider
Charles Cherington415.30%6,779,440$20.07MInsider
Joseph J. Farricielli Jr.413.78%6,754,611$19.99MInsider
Fidelity National Financial Inc 1325.16%5,307,911$15.71MInsider
Matthew Angel213.77%3,489,666$10.33MInsider
John D. Halpern179.28%2,926,551$8.66MInsider
Yiannis Monovoukas103.00%1,681,359$4.98MInsider
Nicholas Jason Singer89.62%1,463,036$4.33MInsider

1 of 3

ERNA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ERNA0.00%100.00%Net Buying
SXTP0.01%99.99%Net Buying
LEXX0.10%49.45%
CANF0.00%0.00%
CLGN0.12%89.37%

Ernexa Therapeutics Stock Ownership FAQ

Who owns Ernexa Therapeutics?

Ernexa Therapeutics (NASDAQ: ERNA) is owned by 0.00% institutional shareholders, 6,230.00% Ernexa Therapeutics insiders, and 0.00% retail investors. Fidelity National Financial Inc is the largest individual Ernexa Therapeutics shareholder, owning 38.43M shares representing 2,354.23% of the company. Fidelity National Financial Inc's Ernexa Therapeutics shares are currently valued at $113.76M.

If you're new to stock investing, here's how to buy Ernexa Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.